CHELONI, GIULIA

CHELONI, GIULIA  

Scienze Biomediche, Sperimentali e Cliniche 'Mario Serio'  

Mostra records
Risultati 1 - 14 di 14 (tempo di esecuzione: 0.026 secondi).
Titolo Data di pubblicazione Autore(i) File
Arachidonate 15-lipoxygenase is required for chronic myeloid leukemia stem cell survival 2014 Y. Chen; C. Peng; S.A. Abraham; Y. Shan; Z. Guo; N.DeSouza; G. Cheloni; D. Li; T. L. Holyoake and S. Li
Chronic myeloid leukaemia stem cells are sensitive to the pharmacological inhibition of hypoxia inducible factor-1a 2015 Giulia Cheloni
ENERGY RESTRICTION REGULATES BCR/ABL EXPRESSION IN CHRONIC MYELOID LEUKAEMIA CELLS VIA TRANSCRIPTIONAL/POST-TRANSCRIPTIONAL CONTROL 2014 Bono S; Lulli M; Di Gesualdo F; Tusa I; Cheloni G; Rovida E; Dello Sbarba P
ERK5-INHIBITION AS A NOVEL APPROACH TO TARGET CML STEM CELLS 2012 I. Tusa; G.Cheloni; NS Gray;X. DengX; E.Rovida; P.Dello Sbarba
GLEEVEC-RESISTANT CML STEM AND PROGENITOR CELLS ARE SENSITIVE TO HIF-INHIBITING DRUGS 2012 G. Cheloni; M. Tanturli; L. Beneforti; E. Rovida; P. Dello Sbarba
Glutamine availability controls bcr/abl protein expression and functional phenotype of chronic myeloid leukemia cells endowed with stem/progenitor cell potential 2021 Poteti M.; Menegazzi G.; Peppicelli S.; Tusa I.; Cheloni G.; Silvano A.; Mancini C.; Biagioni A.; Tubita A.; Mazure N.M.; Lulli M.; Rovida E.; Dello Sbarba P
In Vitro Comparison of the Effects of Imatinib and Ponatinib on Chronic Myeloid Leukemia Progenitor/Stem Cell Features 2020 Tusa I.; Cheloni G.; Poteti M.; Silvano A.; Tubita A.; Lombardi Z.; Gozzini A.; Caporale R.; Scappini B.; Dello Sbarba P.; Rovida E.
Salarin C inhibits maintenance of hypoxia-selected Chronic Myeloid Leukemia progenitor cells 2015 Del Poggetto, E; Tanturli, M; Ben-Califa, N; Gozzini, A; Tusa, I; Cheloni, G; Marzi, I; Cipolleschi, M G; Kashman, Y; Neumann, D; Rovida, E; Dello Sbarba, P
Targeting chronic myeloid leukemia stem cells with ERK5 pathway inhibitors 2018 Tusa, I; Cheloni, G; Poteti, M; Gozzini, A; Deng, X; Gray, N S; Li, S; Dello Sbarba, P; Rovida, E
Targeting chronic myeloid leukemia stem cells with the hypoxia-inducible factor inhibitor acriflavine. 2017 Cheloni, G; Tanturli, M; Tusa, I; Desouza, Nh; Shan, Y; Gozzini, A; Mazurier, F; Rovida, E; Li, S; Dello Sbarba, P.
Targeting the Extracellular Signal-Regulated Kinase 5 Pathway to Suppress Human Chronic Myeloid Leukemia Stem Cells 2018 Ignazia Tusa,Giulia Cheloni, Martina Poteti, Antonella Gozzini, Ngoc Ho DeSouza, Yi Shan, Xianming Deng, Nathanael S. Gray, Shaoguang Li, Elisabetta Rovida, Persio Dello Sbarba
The Leukemic Stem Cell Niche: Adaptation to “Hypoxia” versus Oncogene Addiction 2017 Cheloni, G; Poteti, M; Bono, S; Masala, E; Mazure, N; Rovida, E; Lulli, M; Dello Sbarba, P
The metabolically-modulated stem cell niche: a dynamic scenario regulating cancer cell phenotype and resistance to therapy. 2014 Rovida E; Peppicelli S; Bono S; Bianchini F; Tusa I; Cheloni G; Marzi I; Cipolleschi MG; Calorini L; Dello Sbarba P
Time- and residue-specific differences in histone acetylation induced by VPA and SAHA in AML1/ETO positive leukemia cells 2013 V. Barbetti; A. Gozzini; G. Cheloni; I. Marzi; E. Fabiani; V. Santini; P. Dello Sbarba; E. Rovida